ReviewInternational journal of food science2025
Biobased Organic Nanoparticles: A Promising Versatile Green Tool for Novel Antimicrobial Agents for Improved Safety.
Review in International journal of food science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Biogenic Metal Nanoparticles from Indian Flora as Programmable Bio-Interfaces: From Phytochemical Coronas to Precision Nanomedicine.International journal of molecular sciences · 2026Review
- A WR3-NHMaterials today. Bio · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biobased organic nanoparticles possess nanoscale size, large surface area, tunable surface charge, and strong functionalization capacity, significantly enhancing their antimicrobial performance. Derived from renewable materials such as polysaccharides, proteins, and plant-based compounds, they provide a sustainable and ecofriendly alternative to synthetic antimicrobial agents. Their antimicrobial effects include disrupting microbial membranes, generating reactive oxygen species, and interfering with essential cellular processes, making them effective even against drug-resistant pathogens. Additionally, when used as drug delivery systems, they improve therapeutic outcomes by enhancing compound stability, bioavailability, and targeted delivery while minimizing toxicity. This review comprehensively analyses their structural features, mechanisms of action, and dual roles in infection control and drug delivery. It also addresses key challenges, including nanoparticle stability, scalability, and biosafety. The review concludes with future directions, emphasizing the need to optimize nanoparticle design, understand their interactions with microbial cells, and develop safe, cost-effective, and environmentally friendly synthesis methods to support their broader application in sustainable healthcare.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.